Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» China
China
Germany’s Merck drops China surcharge on orders after US-China tariff deal
Pharma Live
Wed, 05/14/25 - 09:53 am
Merck KGaA
China
tariffs
Qilu Pharmaceutical pays $38M upfront for greater China rights to Minghui's ADC
Fierce Biotech
Fri, 05/9/25 - 09:32 am
Qilu Pharmaceutical
China
Minguhui Pharmaceutical
Illumina outlines $4.18B to $4.26B guidance for 2025 amid China headwinds and strategic cost reductions
MSN/Seeking Alpha
Thu, 05/8/25 - 10:51 pm
Illumina
Medtech
earnings
China
AstraZeneca's China woes recede as focus shifts to upcoming readouts
First Word Pharma
Thu, 05/1/25 - 10:54 am
AstraZeneca
China
AstraZeneca Sales, Earnings Rise; Warns of Mounting Legal Challenges in China
MSN/Wall St Journal
Tue, 04/29/25 - 08:26 am
AstraZeneca
earnings
China
This Pharma Company Is Betting Big On A Chinese Ozempic Rival
Forbes
Sun, 04/13/25 - 11:13 pm
Kailera Therapuetics
obesity
China
R&D
Trump says ‘major’ tariffs coming on pharmaceuticals
BioPharma Dive
Wed, 04/9/25 - 11:46 am
Donald Trump
tariffs
pharma industry
pharma stocks
China
drug manufacturing
US risks losing biotech edge to China, report warns
BioPharma Dive
Tue, 04/8/25 - 10:56 pm
biotech
funding
China
Bayer acquires rights in Puhe BioPharma cancer drug candidate
Reuters
Wed, 03/26/25 - 10:24 am
Bayer
Oral Cancer
Puhe Biopharma
China
ImmuneOnco axes CD47 bispecific as pipeline prioritization pressures hit Chinese biotech
Fierce Biotech
Wed, 03/26/25 - 10:22 am
ImmuneOnco Biopharmaceuticals
China
bispecifics
AstraZeneca details $2.5B investment in China's political center, funding R&D center, biotech pacts
Fierce Biotech
Fri, 03/21/25 - 11:29 am
AstraZeneca
R&D
China
The key factors shaping China’s biopharma boom
Pharma Voice
Thu, 03/20/25 - 09:57 am
China
biotech
tariffs
regulatory
CAR-T
Eli Lilly plans launch of weight-loss drug in emerging markets in 2025, CFO says
MSN/Reuters
Mon, 03/10/25 - 11:09 pm
Eli Lilly
Mounjaro
China
India
Mexico
Brazil
emerging markets
As Tariffs Begin; What Will They Do To Drug Prices And Availability?
Forbes
Wed, 03/5/25 - 11:55 am
tariffs
drug pricing
China
Mexico
Canada
Donald Trump
China bans imports of Illumina's gene sequencers right after Trump tariff action
MSN/Reuters
Tue, 03/4/25 - 10:46 am
Illumina
China
tariffs
Medtech
Donald Trump
Medical Device Manufacturers Eye Costa Rica as Tariff Uncertainty Shakes up Production Strategies
Medtech Dive
Wed, 02/26/25 - 10:19 pm
Medtech
device manufacturing
tariffs
China
Costa Rica
AstraZeneca builds in China as Cosette buys Mayne
Pharmaphorum
Fri, 02/21/25 - 11:09 am
M&A
Cosette
Mayne Pharma
AstraZeneca
China
FibroGen
AstraZeneca deepens China presence with FibroGen deal
BioPharma Dive
Thu, 02/20/25 - 11:52 am
AstraZeneca
FDA
FibroGen
China
roxadustat
Trump’s tariffs will trickle down the clinical trial chain
Clinical Trials Arena
Tue, 02/11/25 - 09:34 pm
tariffs
Donald Trump
clinical trials
China
Tariffs raise concern among generic drugmakers, as advocacy groups seek exemptions
BioPharma Dive
Tue, 02/11/25 - 11:29 am
tariffs
China
Canada
Mexico
Donald Trump
generics
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »